Harbour Investments’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Harbour Investments’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-50	Closed	-$2K	–	4087
2021 Q1	$2K	Buy	+50	New	+$1.25K	﹤0.01%	3308

Harbour Investments's FPRX Position: Q2 2021 in Review

Harbour Investments sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 50 shares — an estimated $2K sold.

Harbour Investments first reported a position in FPRX in Q1 2021 and held it in 1 quarter. The position peaked at $2K in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

Harbour Investments reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
Harbour Investments sold 50 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $2K.
Harbour Investments first reported a position in Five Prime Therapeutics, Inc. in Q1 2021 and held it in 1 quarter.
Harbour Investments's Five Prime Therapeutics, Inc. position peaked at $2K in Q1 2021.
0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on Harbour Investments's 13F filing for Q2 2021, filed 16 Aug 2021.